LATEST NEWS
Servier To License Lucitanib To SIMM In China
Servier and the Shanghai Institute of Materia Medica will collaborate on the development of lucitanib, a targeted antitumor drug candidate with anti-angiogenic effects, in China.
Ironwood, AstraZeneca Initiate Linaclotide PhIII Trial In China
Ironwood and AstraZeneca have initiated a Phase III clinical trial of linaclotide for the treatment of adults with irritable bowel syndrome with constipation.
Reduction In Greenhouse Gases Could Save Chinese Lives, Study
Global abatement of greenhouse gas emissions could save between 0.3-0.7 million premature deaths in the year 2030, two-thirds of which would be in China, reports a new study.
Norgine, Takeda Receive NDA Approval For OBLEAN Tablets 120mg In Japan
The Japanese Ministry of Health, Labor and Welfare has approved an NDA for OBLEAN® Tablets 120mg for the treatment of obesity with complications.
McLaren Applied Technologies Opens APAC HQ In Singapore
McLaren Applied Technologies has established the headquarters of its Asia Pacific operations in Singapore.
The Magic Of Science: Where Did It Go?
How do we win back disillusioned scientists who have transitioned from the starry eyed to the practical? Dr. Laasya Samhita of the Indian Institute of Science, Bangalore writes.
Tiny Diamonds To Boost Leukemia Treatment
Binding an anti-leukemia drug to nano-sized diamonds enhances the delivery of the drug to leukemic cells, boosting its efficacy.
Marine Microbes Are Ocean Travellers
Researchers have shown for the first time the impact of ocean currents on the distribution and abundance of marine micro-organisms.
Tiger Genome Reveals How Big Cats Evolved To Kill
The tiger genome has been sequenced for the first time in a study that has revealed insights into how big cats evolved to become predators.
